Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Cancers|July 9, 2022
A RAS-Independent Biomarker Panel to Reliably Predict Response to MEK Inhibition in Colorectal CancerUlrike Pfohl, Jürgen Loskutov, Sanum Bashir, et al.
Cell Death & Disease|July 3, 2020
Reduced replication origin licensing selectively kills KRAS-mutant colorectal cancer cells via mitotic catastropheBastian Gastl, Kathleen Klotz-Noack, Bertram Klinger, et al.
Cancer Letters|June 10, 2022
Clonality and timing of relapsing colorectal cancer metastasis revealed through whole-genome single-cell sequencingJoao M Alves, Sonia Prado-López, Laura Tomás, et al.
Blood|May 14, 2013
HIF prolyl hydroxylase 2 (PHD2) is a critical regulator of hematopoietic stem cell maintenance during steady-state and stressRashim Pal Singh, Kristin Franke, Joanna Kalucka, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 7, 2019
DNA methylation profiling reliably distinguishes pulmonary enteric adenocarcinoma from metastatic colorectal cancerPhilipp Jurmeister, Anne Schöler, Alexander Arnold, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 30, 2024
Negative Hyperselection of Resistance Mutations for Panitumumab Maintenance in RAS Wild-Type Metastatic Colorectal Cancer (PanaMa Phase II Trial, AIO KRK 0212)Arndt Stahler, Andreas J Kind, Christine Sers, et al.
Cancers|February 13, 2026
YAP1 Enhances Mesenchymal-Type Gene Expression in Human Adrenergic-Type Neuroblastoma CellsMarius Ludwig, Kerstin Ahrens, Annika Winkler, et al.
Genome Medicine|March 1, 2022
DNA methylation reveals distinct cells of origin for pancreatic neuroendocrine carcinomas and pancreatic neuroendocrine tumorsTincy Simon, Pamela Riemer, Armin Jarosch, et al.
EMBO Molecular Medicine|August 19, 2021
Mitogen-activated protein kinase activity drives cell trajectories in colorectal cancerFlorian Uhlitz, Philip Bischoff, Stefan Peidli, et al.
Cancers|July 27, 2022
Serial Analysis of Gene Mutations and Gene Expression during First-Line Chemotherapy against Metastatic Colorectal Cancer: Identification of Potentially Actionable Targets within the Multicenter Prospective Biomarker Study REVEALJörg Kumbrink, Lisa Bohlmann, Soulafa Mamlouk, et al.
Pageof 3